Semaglutide
Product Description
Sinopep-Allsino Biopharmaceutical Co.,Ltd.
-
CN -
2018On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
Specifications
Sinopep-Allsino Biopharmaceutical Co.,Ltd.
-
CN
-
2018On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Sinopep-Allsino Biopharmaceutical Co.,Ltd. (10)
-
Product Fulvestrant
US DMF #33902；
CDE #Y20200001489；
CEP 2021-061
-
Product Lanreotide Acetate
Lanreotide Acetate
US DMF #29693
-
Product Liraglutide
美国 DMF #34104
-
Product Octreotide Acetate
美国 DMF #29710; CDE #Y20180001746
-
Product Oseltamivir Phosphate
US DMF #33907；
CDE #Y20200000736；
Korean registration#20200177785;can provide Oseltamivir Phosphate and its intermediates
-
Product Semaglutide
Peptide API -
Product Thymosin α1 (Thymalfasin)
Thymosin α1
(Thymalfasin)，CDE#Y20170001373
-
Product Tirzepatide
Tirzepatide
-
Product Tirzepatide
Scale up
-
Product Semaglutide
US DMF #036273
CDE #Y20220001086
Sinopep-Allsino Biopharmaceutical Co.,Ltd. resources (1)
-
Brochure Product List from Sinopep
Product List from Sinopep
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance